| Heading: |
Drugs: Prices |
| Question ID: |
1824864 |
| UIN: |
69181 |
| House: |
Commons |
| Date tabled: |
2025-07-18 |
| Asking Member ID: |
5312 |
| Asking Member display name: |
Sadik Al-Hassan
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Sadik Al-Hassan
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify which medicines have a large number of indications |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-08-12 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The criteria will be developed alongside the new proportionate approach to indication-specific pricing arrangements. |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |